ACM
SGYP

Advent Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Advent Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-585
Closed -$102K – 570
2015
Q2 		$102K Buy
+585
New +$2.84K ﹤0.01% 440

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Advent Capital Management's SGYP Position: Q4 2016 in Review

Advent Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2016, closing a stake of 65,000 shares — an estimated $358K sold.

Advent Capital Management first reported a position in SGYP in Q3 2016 and held it in 1 quarter. The position peaked at $358K in Q3 2016. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • Advent Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2016 after selling out during the quarter.
  • Advent Capital Management sold 65,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $358K.
  • Advent Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2016 and held it in 1 quarter.
  • Advent Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $358K in Q3 2016.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on Advent Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.